Dana Investment Advisors Inc. Trims Stake in Pediatrix Medical Group, Inc. $MD

Dana Investment Advisors Inc. cut its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 19.1% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 648,721 shares of the company’s stock after selling 152,741 shares during the period. Dana Investment Advisors Inc. owned approximately 0.76% of Pediatrix Medical Group worth $13,876,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Phocas Financial Corp. boosted its holdings in Pediatrix Medical Group by 44.5% in the 4th quarter. Phocas Financial Corp. now owns 335,551 shares of the company’s stock valued at $7,177,000 after purchasing an additional 103,328 shares in the last quarter. Y Intercept Hong Kong Ltd purchased a new position in shares of Pediatrix Medical Group during the 3rd quarter worth approximately $513,000. Allianz Asset Management GmbH raised its stake in shares of Pediatrix Medical Group by 158.5% during the 3rd quarter. Allianz Asset Management GmbH now owns 158,777 shares of the company’s stock worth $2,660,000 after buying an additional 97,365 shares in the last quarter. American Century Companies Inc. raised its stake in shares of Pediatrix Medical Group by 38.9% during the 3rd quarter. American Century Companies Inc. now owns 2,682,976 shares of the company’s stock worth $44,940,000 after buying an additional 751,109 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC purchased a new position in shares of Pediatrix Medical Group during the 4th quarter worth approximately $13,613,000. 97.71% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. Jefferies Financial Group reissued a “buy” rating and set a $27.00 target price on shares of Pediatrix Medical Group in a research note on Monday, April 20th. Weiss Ratings reissued a “hold (c+)” rating on shares of Pediatrix Medical Group in a research note on Friday, March 27th. UBS Group increased their target price on Pediatrix Medical Group from $22.00 to $25.00 and gave the stock a “neutral” rating in a research note on Tuesday. Mizuho set a $24.00 target price on Pediatrix Medical Group in a research note on Friday, May 8th. Finally, Truist Financial increased their target price on Pediatrix Medical Group from $21.00 to $23.00 and gave the stock a “hold” rating in a research note on Monday, April 13th. One equities research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $22.50.

Pediatrix Medical Group Stock Performance

MD opened at $22.43 on Friday. The stock has a market cap of $1.84 billion, a P/E ratio of 10.89 and a beta of 0.70. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.33 and a quick ratio of 1.33. The stock’s 50 day simple moving average is $21.54 and its 200 day simple moving average is $21.56. Pediatrix Medical Group, Inc. has a 1-year low of $11.84 and a 1-year high of $24.99.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.44 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.07. The business had revenue of $476.20 million for the quarter, compared to analysts’ expectations of $465.83 million. Pediatrix Medical Group had a return on equity of 19.94% and a net margin of 9.02%.The company’s revenue was up 3.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.33 EPS. As a group, equities analysts anticipate that Pediatrix Medical Group, Inc. will post 2.08 EPS for the current fiscal year.

Insider Buying and Selling at Pediatrix Medical Group

In related news, Director Shirley A. Weis sold 36,028 shares of the company’s stock in a transaction that occurred on Wednesday, May 13th. The stock was sold at an average price of $23.75, for a total value of $855,665.00. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.80% of the stock is currently owned by corporate insiders.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.